A case of interstitial cystitis accompanying Sjögren’s syndrome

References

• Parsons CL. Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower uri-nary dysfunction epithelium and potassium recycling. Urology 2003;62:976–82.
   PubMed Web of Science ®Google Scholar
• Holm-Bentzen M, Jacobsen F, Nerstrom B, Lose G, Kristensen JK, Pedersen RH, et al. Painful bladder disease: clinical and pathoanatomical differences in 115 patients. J Urol 1987;138: 500–2.
   Google Scholar
• Johansson SL, Fall M. Clinical features, and spectrum of light microscopic changes in interstitial cystitis. J Urol 1990;143:1118–24.
   PubMed Web of Science ®Google Scholar
• Theoharides TC, Sant GR. Bladder mast cell activation in intersti-tial cystitis. Semin Urol 1991;9:74–87.
   PubMedGoogle Scholar
• Anderson JB, Parivar F, Lee G, Wallington TB, MacIver AG, Bradbrook RA, et al. The enigma of interstitial cystitis-an au-toimmune disease? Br J Urol 1989;63:58–63.
   PubMedGoogle Scholar
• De La Serna AR, Alarcon-Segovia D. Chronic interstitial cystitis as an initial manifestation of systemic lupus erythematosus. J Ftheumatol 1981;8:808–10.
   Google Scholar
• Van De Merwe J, Kamerling R, Arendsen E, Mulder D, Hooijkaas H. Sjögren's syndrome in patients with interstitial cystitis. J Ftheumatol 1993;20:962–6.
   Google Scholar
• Alagiri M, Chottiner S, Ratner V, Slade D, Hanno PM. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997;49:52–7.
   Google Scholar
• Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 1997;49:14–40.
   PubMed Web of Science ®Google Scholar
• Waterman S, Gordon TP, Ftischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neu-rotransmission in Sjögren's syndrome. Arthritis Rheum 2000;43: 1647–54.
   Google Scholar
• Higuchi M, Migita T, Yoshizawa S, Horiuchi T, Nakashima H, Niho Y. Interstitial cystitis in case of primary Sjögren's syndrome (in Japanese). Ryumachi 1998;38:34–8.
   PubMedGoogle Scholar
• Nagaoka M, Tamaoki J, Gotoh S, Nakazawa H, Nagai A. A case of Sjögren's syndrome accompanied by interstitial cystitis and inter-stitial pneumonia improved by Suplatast Tosilate and prednisolone (in Japanese). Arerugi 2003;52:450–3.
   Google Scholar
• Shibata S, Ubara Y, Sawa N, Tagami T, Hosino J, Yokota M, et al. Severe interstitial cystitis associated with Sjögren's syndrome. Intern Med 2004;43:248–52.
   PubMed Web of Science ®Google Scholar
• Gillenwater JY, Wein AJ. Summary of the national institute of arthritis, diabetes, digestive and kidney diseases workshop on in-terstitial cystitis, National Institutes of Health, Bethesda, Mary-land, August 28-29,1987. J Urol 1988;140:203–6.
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective con-certed action supported by the European community. Arthritis Rheum 1993;36:340–7.
   Google Scholar
• Ito T, Mild M, Yamada T. Interstitial cystitis in Japan. BJU Int 2000;86:634–7.
   PubMed Web of Science ®Google Scholar
• Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol 1999;161:549–52.
   Google Scholar
• Oravisto KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Fenn 1975;64:75–7.
   PubMedGoogle Scholar
• Bade JJ, Rijcken B, Mensink HJ. Interstitial cystitis in the Nether-lands: prevalence, diagnostic criteria and therapeutic preferences. J Urol 1995;154:2035–7.
   Google Scholar
• Liebert M, Wedemeyer G, Stein JA, Washington RW Jr, Van Waes C, Carey TE, et al. Evidence for urothelial cell activation in interstitial cystitis. J Urol 1993;149:470–5.
   Google Scholar
• Kerttula TO, Collin P, Polci A, Korpela M, Partanen J, Maki M. Distinct immunologic features of Finnish Sjögren's syndrome patients with HLA alleles DRB1*0301, DQA1*0501, and DQB1*0201. Alternations in circulating T cell receptor gamma/ delta subsets. Arthritis Rheum 1996;39:1733–9.
   Google Scholar
• Christmas TJ. Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol 1994;73:508–15.
   PubMedGoogle Scholar
• Spadaro A, Fticcieri V, Benfari G, Scillone M, Taccari E. Soluble interleukin-2 receptor in Sjögren's syndrome: relation to main serum immunological and immunohistochemical parameters. Clin Ftheumatol 2001;20: 319–23.
   Google Scholar
• Van de Merwe JP, Arendsen HJ. Interstitial cystitis: a review of immunological aspects of the aetiology and pathogenesis, with a hypothesis. BJU Int 2000;85:995–9.
   PubMed Web of Science ®Google Scholar
• Brayer JB, Cha S, Nagashima H, Yasunari U, Lindberg A, Diggs S, et al. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD. IL-4-gene knockout mouse model of Sj8gren's syndrome. Scand J Immunol 2001;54: 133–40.
   Google Scholar
• Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G, et al. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum 2000;43:2297–306.
   PubMed Web of Science ®Google Scholar
• Gao J, Cha S, Jonsson R, Opalko J, Peck AB. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum 2004;50: 2615–21.
   Google Scholar
• Nickel JC, Forrest J, Barkin J, Payne C, Mosbaugh P. Safety and efficacy of up to 900 mg/day polysulfate sodium (elmiron) in patients with Interstitisl cystitis. Urology 2001;57(6 suppl 1):122–3.
   Google Scholar
• Hanno PM, Beuhler J, Wein AJ. Use of amitriptyline in the treat-ment of interstitial cystitis. J Urol 1989;141:846–8.
   Google Scholar
• Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol 1988;140:36–9.
   Google Scholar
• Emtage J, Morales A, Heaton JPW, Perez-Marrero R. Treatment of interstitial cystitis with intravesical heparin. Br J Urol 1994;73: 504–7.
   Google Scholar
• Bristow SE, Hasan ST, Neal DE. TENS: a treatment option for bladder dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 1996;7:185–90.
   PubMedGoogle Scholar
• Ueda T, Tamaki M, Ogawa 0, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T J Urol. 2000;164: 1917–20.
   Google Scholar